Annual Total Liabilities
$22.71 M
+$19.26 M+558.51%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual total liabilities is $22.71 million, with the most recent change of +$19.26 million (+558.51%) on December 1, 2023.
- During the last 3 years, CATX annual total liabilities has risen by +$19.70 million (+654.55%).
- CATX annual total liabilities is now at all-time high.
Performance
CATX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$62.68 M
+$17.76 M+39.54%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly total liabilities is $62.68 million, with the most recent change of +$17.76 million (+39.54%) on September 1, 2024.
- Over the past year, CATX quarterly total liabilities has increased by +$50.93 million (+433.55%).
- CATX quarterly total liabilities is now at all-time high.
Performance
CATX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CATX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +558.5% | +433.6% |
| 3 y3 years | +654.5% | +551.8% |
| 5 y5 years | +1203.8% | +551.8% |
CATX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +654.5% | at high | +2090.9% |
| 5 y | 5-year | at high | +1203.8% | at high | +2187.7% |
| alltime | all time | at high | +5685.0% | at high | >+9999.0% |
Perspective Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $62.68 M(+39.5%) |
| Jun 2024 | - | $44.92 M(-7.2%) |
| Mar 2024 | - | $48.40 M(+113.1%) |
| Dec 2023 | $22.71 M(+558.5%) | $22.71 M(+93.3%) |
| Sep 2023 | - | $11.75 M(+2.2%) |
| Jun 2023 | - | $11.49 M(+19.5%) |
| Mar 2023 | - | $9.62 M(+98.9%) |
| Dec 2022 | $3.45 M(+9.1%) | - |
| Sep 2022 | - | $4.84 M(+52.9%) |
| Jun 2022 | - | $3.16 M(+8.6%) |
| Jun 2022 | $3.16 M(+5.0%) | - |
| Mar 2022 | - | $2.91 M(+1.8%) |
| Dec 2021 | - | $2.86 M(-3.0%) |
| Sep 2021 | - | $2.95 M(-2.0%) |
| Jun 2021 | $3.01 M(+1.1%) | - |
| Jun 2021 | - | $3.01 M(-5.4%) |
| Mar 2021 | - | $3.18 M(+16.1%) |
| Dec 2020 | - | $2.74 M(-6.5%) |
| Sep 2020 | - | $2.93 M(-1.5%) |
| Jun 2020 | $2.98 M(+70.8%) | $2.98 M(-5.3%) |
| Mar 2020 | - | $3.14 M(+12.6%) |
| Dec 2019 | - | $2.79 M(-11.9%) |
| Sep 2019 | - | $3.17 M(+81.9%) |
| Jun 2019 | $1.74 M(-28.2%) | $1.74 M(-11.5%) |
| Mar 2019 | - | $1.97 M(-12.4%) |
| Dec 2018 | - | $2.25 M(+0.5%) |
| Sep 2018 | - | $2.23 M(-7.8%) |
| Jun 2018 | $2.42 M(+45.5%) | $2.42 M(+42.1%) |
| Mar 2018 | - | $1.71 M(+13.2%) |
| Dec 2017 | - | $1.51 M(-7.8%) |
| Sep 2017 | - | $1.64 M(-1.9%) |
| Jun 2017 | $1.67 M(-2.0%) | $1.67 M(-1.6%) |
| Mar 2017 | - | $1.69 M(+19.5%) |
| Dec 2016 | - | $1.42 M(-17.2%) |
| Sep 2016 | - | $1.71 M(+0.6%) |
| Jun 2016 | $1.70 M(-23.4%) | $1.70 M(-25.1%) |
| Mar 2016 | - | $2.27 M(+3.6%) |
| Dec 2015 | - | $2.19 M(+6.1%) |
| Sep 2015 | - | $2.07 M(-6.9%) |
| Jun 2015 | $2.22 M(-14.4%) | $2.22 M(+11.7%) |
| Mar 2015 | - | $1.99 M(-3.4%) |
| Dec 2014 | - | $2.06 M(-2.7%) |
| Sep 2014 | - | $2.12 M(-18.4%) |
| Jun 2014 | $2.59 M(+53.5%) | $2.59 M(+1.9%) |
| Mar 2014 | - | $2.55 M(+49.9%) |
| Dec 2013 | - | $1.70 M(-11.5%) |
| Sep 2013 | - | $1.92 M(+13.7%) |
| Jun 2013 | $1.69 M(+0.1%) | $1.69 M(+8.6%) |
| Mar 2013 | - | $1.55 M(-8.2%) |
| Dec 2012 | - | $1.69 M(+12.6%) |
| Sep 2012 | - | $1.50 M(-10.9%) |
| Jun 2012 | $1.69 M | $1.69 M(+17.2%) |
| Mar 2012 | - | $1.44 M(-18.7%) |
| Dec 2011 | - | $1.77 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $1.60 M(+11.1%) |
| Jun 2011 | $1.44 M(-17.8%) | $1.44 M(-13.0%) |
| Mar 2011 | - | $1.65 M(-43.2%) |
| Dec 2010 | - | $2.91 M(+71.6%) |
| Sep 2010 | - | $1.69 M(-3.0%) |
| Jun 2010 | $1.75 M(-1.8%) | $1.75 M(+1.8%) |
| Mar 2010 | - | $1.72 M(+2.5%) |
| Dec 2009 | - | $1.68 M(-9.1%) |
| Sep 2009 | - | $1.84 M(+3.6%) |
| Jun 2009 | $1.78 M(-12.7%) | $1.78 M(-13.5%) |
| Mar 2009 | - | $2.06 M(+6.9%) |
| Dec 2008 | - | $1.92 M(-6.6%) |
| Sep 2008 | - | $2.06 M(+1.1%) |
| Jun 2008 | $2.04 M(-39.4%) | $2.04 M(-12.5%) |
| Mar 2008 | - | $2.33 M(-18.2%) |
| Dec 2007 | - | $2.85 M(-14.3%) |
| Sep 2007 | - | $3.32 M(-1.1%) |
| Jun 2007 | $3.36 M(+21.3%) | $3.36 M(+33.5%) |
| Mar 2007 | - | $2.52 M(-16.5%) |
| Dec 2006 | - | $3.01 M(+5.1%) |
| Sep 2006 | - | $2.87 M(+3.5%) |
| Jun 2006 | $2.77 M(-87.0%) | $2.77 M(+47.7%) |
| Mar 2006 | - | $1.88 M(-25.2%) |
| Dec 2005 | - | $2.51 M(-54.9%) |
| Sep 2005 | - | $5.56 M(+5801.5%) |
| Jun 2005 | $21.36 M(+5339.4%) | - |
| Mar 2005 | - | $94.20 K(-76.2%) |
| Dec 2004 | - | $396.20 K(+0.9%) |
| Sep 2004 | $392.60 K(-30.5%) | $392.60 K(+1.1%) |
| Jun 2004 | - | $388.50 K(-31.8%) |
| Mar 2004 | - | $569.70 K(+0.3%) |
| Dec 2003 | - | $568.10 K(+0.5%) |
| Sep 2003 | $565.10 K(-47.9%) | $565.10 K(+1.2%) |
| Jun 2003 | - | $558.20 K(-49.0%) |
| Mar 2003 | - | $1.09 M(+0.2%) |
| Dec 2002 | - | $1.09 M(+0.7%) |
| Sep 2002 | $1.08 M(+4.9%) | $1.08 M(+0.4%) |
| Jun 2002 | - | $1.08 M(+1.3%) |
| Mar 2002 | - | $1.07 M(+1.7%) |
| Dec 2001 | - | $1.05 M(+1.4%) |
| Sep 2001 | $1.03 M(-19.5%) | $1.03 M(-22.6%) |
| Jun 2001 | - | $1.34 M(+1.8%) |
| Mar 2001 | - | $1.31 M(-5.7%) |
| Dec 2000 | - | $1.39 M(+8.4%) |
| Sep 2000 | $1.28 M(+4.8%) | $1.28 M(+1.5%) |
| Jun 2000 | - | $1.26 M(+1.0%) |
| Mar 2000 | - | $1.25 M(+1.0%) |
| Dec 1999 | - | $1.24 M(+1.1%) |
| Sep 1999 | $1.23 M(-63.0%) | $1.23 M |
| Sep 1998 | $3.31 M(-2.2%) | - |
| Sep 1997 | $3.38 M(-7.1%) | - |
| Sep 1996 | $3.64 M(+39.8%) | - |
| Sep 1995 | $2.61 M(+1.0%) | - |
| Sep 1994 | $2.58 M | - |
FAQ
- What is Perspective Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Perspective Therapeutics?
- What is Perspective Therapeutics annual total liabilities year-on-year change?
- What is Perspective Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly total liabilities year-on-year change?
What is Perspective Therapeutics annual total liabilities?
The current annual total liabilities of CATX is $22.71 M
What is the all time high annual total liabilities for Perspective Therapeutics?
Perspective Therapeutics all-time high annual total liabilities is $22.71 M
What is Perspective Therapeutics annual total liabilities year-on-year change?
Over the past year, CATX annual total liabilities has changed by +$19.26 M (+558.51%)
What is Perspective Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CATX is $62.68 M
What is the all time high quarterly total liabilities for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly total liabilities is $62.68 M
What is Perspective Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CATX quarterly total liabilities has changed by +$50.93 M (+433.55%)